glp 1 missed dose How to Restart Semaglutide GLP-1s are one of the

Novo Nordisk will collaborate with EMA to update the EU SmPC and patient leaflets

Glucagon-like peptide-2 receptor activation in the rat intestinal mucosa

Diabetes mellitus is a glucose metabolism disorder characterized by chronic hyperglycemia resulting from a deficit in insulin production and/or action

Felix Beuschlein has received financial support for attending symposia and for educational programmes by Novo Nordisk

Long-Term Weight Loss Continued treatment with GLP-1 agonists has been associated with sustained weight loss over time

So far, body weight management should be addressed as one of the leading therapeutic goals in T2D, with stringent targets must be achieved (71)